New hope for breast cancer patients as life-extending drug now on NHS in England

Enhertu, a breast cancer drug, is now available on the National Health Service in England. The medication has been prescribed in Scotland for more than two years. Clinical data showed patients receiving the drug lived an average of seven additional months compared to a control group.

Next story